Stock market announcement archive

Lifecare AS – New share capital registered

November 3, 2022
Reference is made to the stock exchange announcement published on 26 October2022 by Lifecare AS (the "Company") announcing the successful completion of aprivate placement of new shares in the Company, with gross proceeds of NOK 45million (the "Private Placement"). The share capital increase related to the Private Placement has been registeredin the Norwegian Register of […]
Read more

LIFE: Cancellation of subsequent offering by Lifecare AS

November 3, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published on 26 October2022 by […]
Read more

LIFE: Key information relating to subsequent offering by Lifecare AS

October 27, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published on 26 October2022 by […]
Read more

Lifecare AS – Transactions by closely associated parties of primary insiders

October 26, 2022
Reference is made to the stock exchange announcement by Lifecare AS (the"Company") on 26 October 2022 regarding the successful placing of a privateplacement of new shares (the "Offer Shares") with gross proceeds ofapproximately NOK 45 million (the "Private Placement"). Please see the attached form for details on transactions conducted by a closelyassociated party of a […]
Read more

Lifecare – Successful completion of private placement

October 26, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the announcement published on 26 October 2022 by LifecareAS […]
Read more

Lifecare – Contemplated private placement

October 26, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Lifecare AS ("Lifecare" or the "Company") has retained Carnegie AS as bookrunnerand manager […]
Read more

Presentation on Nordic Life Science Congress and updated Investor Presentation – Lifecare Newsletter

October 7, 2022
Bergen, Norway 7 October 2022 Watch Lifecare's company presentation at the LSX Nordic Congress for LiceScience and Investor executives in Copenhagen, take a look at our updatedinvestor presentation and our new animation video explaining our technology. Read more in Lifecare's newsletter:https://lifecare.no/news/information-from-lifecare-october-2022/This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for […]
Read more

LIFE: Interim data analysis of the first in-human study shows that Lifecare’s sensor is able to monitor glucose variations

September 27, 2022
Conducting clinical trials on humans is a significant step towards Lifecare'sgoal of contributing to helping people with diabetes to live a normal life. The purpose of the first study is to optimize signal reading from the company'sgroundbreaking sensor technology for continuous glucose monitoring for peoplewith diabetes. The glucose sensor for the clinical trials is produced […]
Read more

Lifecare signs Letter of Intent – Production location in Mainz

September 14, 2022
Bergen, Norway 14.9.22 Lifecare AS (Lifecare) has signed a Letter of Intent (LOI) with InnovationsparkMainz GmbH & Co KG (IVP). On this basis Lifecare and IVP will initiate anintensive joint development of a new Lifecare manufacturing location in Mainz(Germany), with an optimized infrastructure for sensor-production. In additionto production, Lifecare intends to integrate and co-locate the […]
Read more

Lifecare semi-annual report – strategic measures lead to strong increase in external revenue and increased operational capacity

August 25, 2022
Bergen, 25 August 2022. Today, Lifecare present strong financial results following the first half-yearwith operational activities in two German subsidiaries as part of the LifecareGroup. The external revenue in 1H 2022 reached a total of 8,7MNOK, representingan increase of +8,7MNOK from 1H 2021 (from 0,0 MNOK) and +7,1MNOK from EY 2021(from 1,6MNOK). A steep increase […]
Read more